FDA's role in the evaluation of Avandia's safety
Subtitle: hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007.
Publisher: U.S. G.P.O.; For sale by the Supt. of Docs., U.S. G.P.O.
Published: 2008
Place of publication: Washington
Language: eng
Number of pages: 138
ISBN-13: 9780160825880
Subjects: United States. -- Food and Drug Administration; Rosiglitazone -- Side effects; Diabetes -- Chemotherapy; Drugs -- United States -- Testing
Notes: Shipping list no.: 2009-0225-P.

"Serial no. 110-76."

Includes bibliographical references (p. 23).